Johnson & Johnson saw the highest growth of 140% in patent filings in November and 128% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 97% and grants by 128%. GlobalData’s DataBook provides a comprehensive analysis of Johnson & Johnson’s patent filings and grants. Buy the databook here.
Johnson & Johnson has been focused on protecting inventions in United States(US) with 21 publications in Q4 2023
The United States(US) Patent Office dominates the patent filings and grants with nearly 52% filings and 62% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and South Korea(KR) patent Office are among the top ten patent offices where Johnson & Johnson is filings its patents. Among the top granted patent authorities, Johnson & Johnson has 62% of its grants in United States(US), 25% in European Patent Office(EPO) and 12% in Poland(PL).
Intuitive Surgical could be the strongest competitor for Johnson & Johnson
General surgery devices related patents lead Johnson & Johnson portfolio followed by orthopedic devices, and healthcare it
Johnson & Johnson has highest number of patents in general surgery devices followed by orthopedic devices, healthcare it, other remote patient monitoring, and diagnostic imaging. For general surgery devices, nearly 21% of patents were filed and 23% of patents were granted in Q4 2023.
For comprehensive analysis of Johnson & Johnson's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.